DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,495,143 | +3.1% | 22,149 | -0.3% | 1.94% | +4.6% |
| Q2 2023 | $5,330,880 | -4.8% | 22,212 | -0.1% | 1.86% | -14.3% |
| Q1 2023 | $5,602,565 | -5.3% | 22,229 | -0.2% | 2.17% | -9.6% |
| Q4 2022 | $5,913,038 | +2.0% | 22,279 | -0.7% | 2.40% | -9.6% |
| Q3 2022 | $5,797,000 | -0.4% | 22,444 | -2.2% | 2.65% | +15.0% |
| Q2 2022 | $5,819,000 | -13.7% | 22,952 | -0.1% | 2.31% | +5.3% |
| Q1 2022 | $6,742,000 | -10.8% | 22,984 | +0.1% | 2.19% | +3.6% |
| Q4 2021 | $7,556,000 | +7.7% | 22,966 | -0.3% | 2.11% | +5.6% |
| Q3 2021 | $7,016,000 | +12.2% | 23,045 | -1.1% | 2.00% | +13.2% |
| Q2 2021 | $6,254,000 | +19.0% | 23,304 | -0.2% | 1.77% | +7.3% |
| Q1 2021 | $5,254,000 | -0.5% | 23,342 | -1.8% | 1.65% | +0.8% |
| Q4 2020 | $5,282,000 | +3.1% | 23,780 | 0.0% | 1.63% | -2.2% |
| Q3 2020 | $5,121,000 | +7.0% | 23,780 | -12.2% | 1.67% | -2.2% |
| Q2 2020 | $4,787,000 | +15.7% | 27,072 | -5.4% | 1.71% | +5.5% |
| Q1 2020 | $4,139,000 | -6.1% | 28,626 | -0.3% | 1.62% | -2.5% |
| Q4 2019 | $4,407,000 | +5.8% | 28,713 | -0.5% | 1.66% | -2.8% |
| Q3 2019 | $4,167,000 | +1.0% | 28,854 | -0.1% | 1.71% | +3.3% |
| Q2 2019 | $4,127,000 | +5.8% | 28,877 | -2.3% | 1.65% | +0.3% |
| Q1 2019 | $3,900,000 | +26.4% | 29,542 | -1.3% | 1.65% | +10.8% |
| Q4 2018 | $3,086,000 | -7.6% | 29,922 | -2.7% | 1.49% | +6.6% |
| Q3 2018 | $3,340,000 | +6.3% | 30,742 | -3.5% | 1.40% | -0.1% |
| Q2 2018 | $3,142,000 | +0.8% | 31,845 | 0.0% | 1.40% | -1.8% |
| Q1 2018 | $3,118,000 | +5.7% | 31,845 | +0.2% | 1.42% | +2.4% |
| Q4 2017 | $2,950,000 | +8.0% | 31,783 | -0.2% | 1.39% | +0.6% |
| Q3 2017 | $2,732,000 | +1.5% | 31,853 | -0.1% | 1.38% | -0.9% |
| Q2 2017 | $2,692,000 | +1.3% | 31,896 | 0.0% | 1.39% | -1.3% |
| Q1 2017 | $2,658,000 | +6.2% | 31,896 | -0.9% | 1.41% | -2.3% |
| Q4 2016 | $2,504,000 | -0.6% | 32,171 | +0.1% | 1.44% | +1.2% |
| Q3 2016 | $2,518,000 | -22.4% | 32,131 | 0.0% | 1.43% | -25.9% |
| Q2 2016 | $3,245,000 | +6.1% | 32,131 | -0.3% | 1.92% | +8.6% |
| Q1 2016 | $3,057,000 | +5.7% | 32,224 | +3.5% | 1.77% | +12.2% |
| Q4 2015 | $2,892,000 | +9.1% | 31,136 | +0.1% | 1.58% | +2.7% |
| Q3 2015 | $2,650,000 | -0.6% | 31,101 | -0.2% | 1.54% | +2.8% |
| Q2 2015 | $2,666,000 | +1.2% | 31,151 | +0.4% | 1.50% | +2.7% |
| Q1 2015 | $2,635,000 | -0.8% | 31,035 | +0.2% | 1.46% | +5.4% |
| Q4 2014 | $2,655,000 | +12.7% | 30,982 | -0.1% | 1.38% | +6.7% |
| Q3 2014 | $2,355,000 | -3.7% | 31,005 | -0.2% | 1.30% | +2.9% |
| Q2 2014 | $2,445,000 | +3.2% | 31,055 | -1.7% | 1.26% | -2.2% |
| Q1 2014 | $2,370,000 | -2.7% | 31,594 | +0.1% | 1.29% | -3.2% |
| Q4 2013 | $2,437,000 | +10.1% | 31,569 | -1.2% | 1.33% | -0.4% |
| Q3 2013 | $2,214,000 | +8.6% | 31,942 | -0.8% | 1.33% | +2.8% |
| Q2 2013 | $2,038,000 | – | 32,195 | – | 1.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |